Cargando…
miR-145 as a Potential Biomarker and Therapeutic Target in Patients with Non-Small Cell Lung Cancer
Our previous study found that miR-145 was downregulated in non-small cell lung cancer (NSCLC) tissues and that it could inhibit the cell proliferation in transfected NSCLC cells. In this study, we found that miR-145 was downregulated in NSCLC plasma samples compared to healthy controls. A receiver o...
Autores principales: | Cho, William C., Wong, Chi F., Li, Kwan P., Fong, Alvin H., Fung, King Y., Au, Joseph S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298104/ https://www.ncbi.nlm.nih.gov/pubmed/37373169 http://dx.doi.org/10.3390/ijms241210022 |
Ejemplares similares
-
Plasma miR-145, miR-20a, miR-21 and miR-223 as novel biomarkers for screening early-stage non-small cell lung cancer
por: Zhang, Hui, et al.
Publicado: (2017) -
Diagnostic value of serum miR197 and miR145 in non-small cell lung cancer
por: Sui, Ankui, et al.
Publicado: (2019) -
miR-31 and miR-145 as Potential Non-Invasive Regulatory
Biomarkers in Patients with Endometriosis
por: Bashti, Oranous, et al.
Publicado: (2018) -
miR-31 and miR-145 as Potential Non-Invasive Regulatory
Biomarkers in Patients with Endometriosis
por: Bashti, Oranous, et al.
Publicado: (2018) -
Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease
por: Faccini, Julien, et al.
Publicado: (2017)